ABL Bio shares fall on disappointment over U.S. clinical trial results for bile duct cancer treat... 신민준 2026.04.29 오전 08:00 Surge in Bio Stocks...TiumBio and ST Pharm Outlook Brightens on Solid Performance [K-Bio Pulse] 유진희 2026.04.28 오전 08:00 Geopolitical Risks Refocus Market on Undervalued Bio Gems...Woojung Bio·Geninus Surge[K-Bio Puls... 유진희 2026.03.09 오전 08:00 ABL Bio Shares Surge on GSK Licensing Deal [K-Bio Pulse] 김진수 2025.04.08 오전 07:58 [임상 업데이트] 유한양행, 면역 항암 신약 임상 1·2상 승인 김진수 2025.04.12 오후 01:51 Biotech Rallies as Four Firms Join Korea’s Top 10 Stock Gainers[K-Bio Pulse] 유진희 2025.05.28 오전 07:48 ABL Bio Boosts Tech Export Potential Amid Big Deal, Biotech Demand Soars[K-bio Pulse] 김새미 2025.11.12 오후 06:05 2% Royalty Shock at Alteogen Ripples Through Korean Biotech[K-Bio Pulse] 김새미 2026.01.22 오전 08:00 Oncocross Soars on Diversification Hopes, ABL Bio Slides on Trial Data[K-Bio Pulse] 송영두 2025.04.03 오전 08:08 CellBion Jumps Over 10% on Expanded Combo Trial With Keytruda [K-Bio Pulse] 김진수 2025.03.27 오전 08:29 더 보기 로딩중..